Latest news
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 12:00:00 GMTAurinia's First FDA-Approved Oral Therapy for Lupus Nephritis Generates $79.4M - Stock TitanStock Titan · Thu, 06 Aug 2026 12:00:00 GMTViridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results - Business WireBusiness Wire · Thu, 06 Aug 2026 11:01:00 GMTAlnylam Pharmaceuticals Reports Second Quarter 2026 Financial Results and Highlights Recent Period Progress - Business WireBusiness Wire · Thu, 30 Jul 2026 07:00:00 GMTDemonstrate Progress on Recently Upgraded Springboard Plan - Business WireBusiness Wire · Tue, 28 Jul 2026 11:01:00 GMT